Summary
- The government in South Korea is securing and distributing additional COVID-19 treatments to combat a resurgence of infections.
- The recent surge in cases is primarily led by KP.3, an Omicron subvariant.
- Hospitalizations have increased significantly, prompting an expansion of the response team against COVID-19.
